chevron_left Categories

Other related webinars

Essential Regulatory Perspectives and Best Clini...

Monday, 7th February, 2011
Time : 01:00 PM EST | 10:00 AM PST

Biggest challenge for Pharmaceuticals/ Biotechno...

Tuesday, 22nd February, 2011
Time : 10:00 AM | 07:00 AM

Critical aspects of applying QbD to pharmaceutic...

Friday, 6th May, 2011
Time : 02:00 PM | 11:00 AM

Biologics Battlefield: Opportunities and Obstacl...

Thursday, 30th June, 2011
Time : 02:00 PM | 11:00 AM

Vital Success/Failure Regulatory Perspectives an...

Thursday, 15th September, 2011
Time : 02:00 PM | 11:00 AM

Good Laboratory Practices (GLP) Compliance and A...

Friday, 11th November, 2011
Time : 02:00 PM | 11:00 AM

Good Clinical Practice (GCP): FDA Regulations, S...

Thursday, 26th January, 2012
Time : 02:00 PM EST | 11:00 AM PST

Orphan Drugs in Europe – How to use observatio...

Friday, 1st June, 2012
Time : 02:00 PM EST | 11:00 AM PST

Implementing the Compliant Good Laboratory Pract...

Friday, 10th August, 2012
Time : 02:00 PM EST | 11:00 AM PST

An overview of an innovative patient-centric ser...

Wednesday, 12th September, 2012
Time : 02:00 PM EST | 11:00 AM PST

An overview of Translational Medicine

Friday, 21st September, 2012
Time : 02:00 PM EST | 11:00 AM PST

Optimizing Site Selection for Global Clinical Tr...

Friday, 26th October, 2012
Time : 02:00 PM EST | 11:00 AM PST

Optimal clinical supply planning for global drug...

Friday, 16th November, 2012
Time : 02:00 PM EST | 11:00 AM PST

Patient Recruitment & Retention Management in Cl...

Monday, 10th December, 2012
Time : 02:00 PM EST | 11:00 AM PST

GMP's for Dietary Supplements: Keys to Success w...

Thursday, 30th October, 2014
Time : 01:00 PM EST | 10:00 AM PST

Is It Safe? A Cautionary Tale and Practical Guid...

Friday, 9th January, 2015
Time : 02:00 PM EST | 11:00 AM PST

How To Reconcile ICH GCP With RISK BASED Monitor...

Thursday, 19th March, 2015
Time : 11:00 AM IST | 06:30 PM BET

Orphan Drugs : Regulation and Reimbursement Cond...

Friday, 22nd July, 2016
Time : 01:00 PM EST | 10:00 AM PST

Panel Discussion on Best Practices to Clinical T...

Friday, 10th March, 2017
Time : 04:00 PM IST | 11:30 AM BST

FDA Requirements for Good Clinical Practice’s ...

Friday, 7th July, 2017
Time : 04:00 PM IST | 11:30 AM BST

Implementation of Pharmaceutical Quality system ...

Friday, 17th November, 2017
Time : 01:00 PM EST | 10:30 AM PST

FDA Guidance for ICH GCP E6 R2 Means for Sponsor...

Thursday, 27th September, 2018
Time : 04:00 PM IST | 03:30 AM PDT

Managing Human Error in Quality Systems: Human E...

Friday, 17th July, 2020
Time : 01:00 PM EST | 10:00AM PST

FDA approvals of Orphan Drugs and Rare Diseases:...

Friday, 24th July, 2020
Time : 01:00 PM EST | 10:30 AM PST

FDA approvals of Orphan Drugs and Rare Diseases:...

Friday, 26th August, 2022
Time : 01:00 PM EST | 10:00 AM PST

Good Documentation Guideline (Chapter <1029> USP...

Friday, 11th November, 2022
Time : 01:00 PM EDT | 10:00 AM PST

FDA - Investigating OOS results

Friday, 17th March, 2023
Time : 01:00 PM EDT | 10:00 AM PDT

Best Practices for FDA's Investigating Deviation...

Friday, 26th May, 2023
Time : 01:00 PM EDT | 10:00 AM PDT

Recorded Webinar

Implementation of Pharmaceutical Quality system ICH Q10

timelapse 60 Min with 15 Min QnA of Q and A

Note:

This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times

Speaker/Presenter

Short Abstract

ICH Q10 Describes harmonized Pharmaceutical Quality system model which is at implementation stage by three regulatory bodies to ICH i.e. from united states, Europe and Japan.This Quality system model can be applied effectively by organization at all product life cycle stages i.e. during product development, technology transfer, commercial manufacturing and product discontinuation. Elements of Pharmaceutical quality systems can be systematically utilized to enhance process performance and product quality. This is by achieving ICH objectives i.e. achieving product realization, maintaining state of control and continual improvement. Quality risk management and effective utilization of knowledge at all stages of product helps in achieving these objectives and hence enable organization to implement ICH Q10 effectively.
Key Areas Covered During the Webinar:

  • Brief on Pharmaceutical Quality system ICH Q10 & its need.
  • Understanding of Scope and objectives of ICH Q10
  • How ICH Q10 can be implemented effectively.
  • How to design Pharmaceutical Quality system.
  • Importance of management role & responsibilities.
  • How to manage process performance and product quality in your organization.
  • How to keep continual improvements in Pharmaceutical Quality system.


Apply for this webinar

Content Disclaimer

Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.

//